Clinical trial
HbA1c as an Early Serologic Marker for the Hemodynamic Progression of Stage A Heart
NCT04450576 is registered in ClinicalTrials.gov with Parkview Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HbA1c as an Early Serologic Marker for the Hemodynamic Progression of Stage A Heart
- Lead sponsor
- Parkview Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 20, 2019
- Completion date
- December 30, 2020
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.